The latest trading session saw Cresco Labs Inc. (CRLBF) ending at $2, denoting no adjustment from its last day’s close. This change was narrower than the S&P 500’s daily loss of 1.2%. On the other hand, the Dow registered a loss of 0.65%, and the technology-centric Nasdaq decreased by 1.79%.
Shares of the company have appreciated by 5.82% over the course of the past month, outperforming the Medical sector’s loss of 6.57% and the S&P 500’s loss of 0.85%.
Market participants will be closely following the financial results of Cresco Labs Inc. in its upcoming release. On that day, Cresco Labs Inc. is projected to report earnings of -$0.02 per share, which would represent year-over-year growth of 77.78%. At the same time, our most recent consensus estimate is projecting a revenue of $183.31 million, reflecting a 5.61% fall from the equivalent quarter last year.
For the full year, the Zacks Consensus Estimates are projecting earnings of -$0.07 per share and revenue of $743.73 million, which would represent changes of +58.82% and -3.52%, respectively, from the prior year.
It’s also important for investors to be aware of any recent modifications to analyst estimates for Cresco Labs Inc. These latest adjustments often mirror the shifting dynamics
